Results 151 to 160 of about 284,324 (192)

Oncolytic viruses: A novel therapeutic approach for pancreatic cancer. [PDF]

Mol Ther Oncol
Esteves M, Matos AM, Cruz MT.
europepmc   +1 more source

EGFRxCD16 bispecific antibodies orchestrate superior NK cell-mediated lysis of ovarian cancer and NSCLC cell lines in combination with oncolytic viruses. [PDF]

Cancer Immunol Immunother
Gahbauer S, Poiret T.
europepmc   +1 more source

Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas. [PDF]

Mol Ther Oncol
Vazaios K, Tallon-Cobos AC, van Oosterhout LPJ, Waranecki P, Cornel AM, Dautzenberg NMM, van Hoesel M, Forbes C, Nierkens S, Kemp V, Hoeben RC, van der Lugt J, Calkoen FG, Hulleman E.   +13 more
europepmc   +1 more source

Oncolytic Viruses in Glioblastoma: Clinical Progress, Mechanistic Insights, and Future Therapeutic Directions. [PDF]

Cancers (Basel)
Liu J, Wang Y, Su S, Cheng G, Zhao H, Sun J, Sun G, Li F, Hui R, Liu M, Wu L, Wu D, Yang F, Dang Y, Hei J, Li Y, Gao Z, Wang B, Bai Y, Lv W, Zhang J.   +20 more
europepmc   +1 more source

Recombinant Oncolytic Viruses: Hexagonal Warriors in the Field of Solid Tumor Immunotherapy. [PDF]

Curr Issues Mol Biol
Zhang C, Sun Q.
europepmc   +1 more source

Oncolytic viruses targeting CD47: a new road to success? [PDF]

J Immunother Cancer
Takimoto CH, Wick MJ.
europepmc   +1 more source

Analysis of oncolytic adenovirus dl922-947 effects on anaplastic thyroid carcinoma cells (ATC) and potential therapeutic associations [PDF]

, 2008
Iacuzzo, Irma
core  

Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defenses. [PDF]

Front Immunol
Omolekan TO, Folahan JT, Tesfay MZ, Mohan H, Dutta O, Rahimian L, Ferdous KU, Ghavimi R, Cios A, Beng TK, Francis J, D'Auvergne O, Borad MJ, Kousoulas KG, DiGiuseppe S, Nagalo BM, Chamcheu JC.   +16 more
europepmc   +1 more source

Design and Efficacy of Oncolytic Viruses and Antitumor Vaccines: A Dead End in the Immunotherapy of Pancreatic Cancer? [PDF]

Int J Mol Sci
Achim E, Pîrlici E, Cristea C, Tertis M.   +3 more
europepmc   +1 more source